Germany Insulin Delivery Market Outlook to 2025

Pages: 50 Published: April 30, 2020 Report Code: GDMECC5018DB

GlobalData’s “Germany Insulin Delivery Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Germany Insulin Delivery market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Insulin Pens and Insulin Pumps.

The Germany Insulin Delivery Market report provides key information and data on:

• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.

• 2019 company share and distribution share data for Insulin Delivery Market.

• Global corporate-level profiles of key companies operating within the Germany Insulin Delivery Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Germany Insulin Delivery Tests is segmented as follows:

• Insulin Pens and Insulin Pumps

Reasons to Buy

Key Reasons to Purchase – The Germany Insulin Delivery Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key Players

Key companies covered in the “Germany Insulin Delivery Market Outlook to 2025” report:

• Novo Nordisk AS

• Sanofi

• Eli Lilly and Co

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 What Is This Report About? 5

2.2 Insulin Delivery Market Segmentation 5

2.3 Definitions of Markets Covered in the Report 6

3 Insulin Delivery Market, Germany 7

3.1 Insulin Delivery Market, Germany, Revenue ($m), 2015-2025 7

3.1.1 Insulin Pens Market, Germany, Revenue ($m), by Segment, 2015-2025 9

3.1.2 Insulin Pumps Market, Germany, Revenue ($m), by Segment, 2015-2025 11

3.2 Insulin Delivery Market, Germany, Volume (Units), 2015-2025 13

3.2.1 Insulin Pens Market, Germany, Volume (Units), by Segment, 2015-2025 15

3.2.2 Insulin Pumps Market, Germany, Volume (Units), by Segment, 2015-2025 17

3.3 Insulin Delivery Market, Germany, Average Price ($), 2015-2025 19

3.4 Insulin Delivery Market, Germany, Distribution Share by Revenue ($m), 2019 20

3.5 Insulin Delivery Market, Germany, Company Share by Revenue ($m), 2019 21

4 Overview of Key Companies in Germany, Insulin Delivery Market 23

4.1 Novo Nordisk AS 23

4.1.1 Company Overview 23

4.2 Sanofi 23

4.2.1 Company Overview 23

4.3 Eli Lilly and Co 23

4.3.1 Company Overview 23

4.4 Medtronic Plc 24

4.4.1 Company Overview 24

4.5 F. Hoffmann-La Roche Ltd 24

4.5.1 Company Overview 24

4.6 Ypsomed Holding AG 24

4.6.1 Company Overview 24

4.7 Insulet Corp 25

4.7.1 Company Overview 25

5 Insulin Delivery Market Pipeline Products 26

6 Financial Deals Landscape 27

6.1 Debt Offerings 27

6.1.1 Bayer Raises USD1.1 Billion in Private Placement of

2.375% Bonds Due 2079 27

6.1.2 Bayer Raises USD830.7 Million in Private Placement of

3.125% Bonds Due 2079 28

7 Recent Developments 29

7.1 Corporate Communications 29

7.1.1 Feb 22, 2020: Bayer Cares Foundation donates over EUR 363,000 to support 94 social projects in 32 countries worldwide 29

7.1.2 Sep 10, 2019: Bayer reduces size of board of management from seven to five members 29

7.1.3 Sep 03, 2019: Bayer appoints Marianne De Backer Head of Pharmaceuticals Business Development & Licensing and Member of Executive Committee 30

7.1.4 Apr 16, 2019: Ginkgo Bioworks appoints former Bayer CEO Marijn Dekkers as Chairman of its Board of Directors 31

7.1.5 Apr 12, 2019: Dr. Monika Lessl to lead both the Bayer Science and the Bayer Cares Foundations 31

7.2 Financial Announcements 32

7.2.1 Jul 30, 2019: Bayer on track in operational business 32

7.3 Other Significant Developments 34

7.3.1 Feb 27, 2020: Bayer reaches agreement with stockholder Prof. Strenger on voluntary special audit of due diligence procedures 34

7.3.2 Dec 10, 2019: Bayer to significantly step-up its sustainability efforts 35

7.3.3 Oct 21, 2019: CRISPR Therapeutics and Bayer announce an update on Casebia Therapeutics 37

7.3.4 May 23, 2019: Ypsomed increases EBIT and invests in long-term profitability 37

7.3.5 Apr 25, 2019: Bayer: strong operational start to the year 39

7.4 Strategy And Business Planning 42

7.4.1 Aug 22, 2019: Ypsomed opens production plant in Schwerin 42

8 Appendix 44

8.1 Research Methodology 45

8.1.1 Coverage 45

8.1.2 Secondary Research 45

8.1.3 Primary Research 46

8.1.4 Market Modeling and Forecasting 47

8.1.5 Company Share Analysis 48

8.1.6 Distribution Share Analysis 48

8.1.7 Benchmarking 49

8.2 GlobalData Consulting 49

8.3 Contact Us 50

8.4 Disclaimer 50

List of Tables

1.1 List of Tables

Table 1: Insulin Delivery Market, Germany, Revenue ($m), USD Constant, 2015-2020 8

Table 2: Insulin Delivery Market, Germany, Revenue ($m), USD Constant, 2021-2025 8

Table 3: Insulin Pens Market, Germany, Revenue ($m), USD Constant, 2015-2020 10

Table 4: Insulin Pens Market, Germany, Revenue ($m), USD Constant, 2021-2025 10

Table 5: Insulin Pumps Market, Germany, Revenue ($m), USD Constant, 2015-2020 12

Table 6: Insulin Pumps Market, Germany, Revenue ($m), USD Constant, 2021-2025 12

Table 7: Insulin Delivery Market, Germany, Volume (Units), 2015-2020 14

Table 8: Insulin Delivery Market, Germany, Volume (Units), 2021-2025 14

Table 9: Insulin Pens Market, Germany, Volume (Units), 2015-2020 16

Table 10: Insulin Pens Market, Germany, Volume (Units), 2021-2025 16

Table 11: Insulin Pumps Market, Germany, Volume (Units), 2015-2020 18

Table 12: Insulin Pumps Market, Germany, Volume (Units), 2021-2025 18

Table 13: Insulin Delivery Market, Germany, Average Price ($), 2015-2020 19

Table 14: Insulin Delivery Market, Germany, Average Price ($), 2021-2025 19

Table 15: Insulin Delivery Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2019 20

Table 16: Insulin Delivery Market, Germany, Company Share by Revenue ($m), USD Constant, 2019 22

Table 17: Insulin Delivery Market Pipeline Products 26

Table 18: Bayer Raises USD1.1 Billion in Private Placement of 2.375% Bonds Due 2079 27

Table 19: Bayer Raises USD830.7 Million in Private Placement of 3.125% Bonds Due 2079 28

List of Figures

1.2 List of Figures

Figure 1: Insulin Delivery Market, Germany, Revenue ($m), USD Constant, 2015-2025 7

Figure 2: Insulin Pens Market, Germany, Revenue ($m), USD Constant, 2015-2025 9

Figure 3: Insulin Pumps Market, Germany, Revenue ($m), USD Constant, 2015-2025 11

Figure 4: Insulin Delivery Market, Germany, Volume (Units), 2015-2025 13

Figure 5: Insulin Pens Market, Germany, Volume (Units), 2015-2025 15

Figure 6: Insulin Pumps Market, Germany, Volume (Units), 2015-2025 17

Figure 7: Insulin Delivery Market, Germany, Company Share (%) 2019 21

Frequently Asked Questions

Enquire Before Buying
$4995

Can be used by individual purchaser only

$14985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.